Creative Medical Technology Holdings Announces FDA Clearance of Investigational New Drug (IND) Application for AlloStem™, a Novel Cell Therapy for the Treatment of Type 1 Diabetes

/PRNewswire/ -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), an immuno-endocrine company working to revolutionize care through the development of...

Related Keywords

Florida ,United States ,Phoenix ,Arizona ,University Of Miami ,Timothy Warbington ,Camillo Ricordi ,Diabetes Research Institute ,Company Investigational New Drug ,Drug Administration ,Nasdaq ,Creative Medical Technology Holdings Inc ,Creative Medical Technology Holdings ,Prnewswire Creative Medical Technology Holdings Inc ,Perinatal Stem Cell Society Congress Workshop ,Cell Transplant Program ,Medical Technology Holdings ,Investigational New Drug ,Perinatal Tissue Derived ,Stacy Joy Goodman Professor ,Distinguished Professor ,Biomedical Engineering ,Cell Transplant ,Perinatal Stem Cell Society ,Nc ,